Navigation Links
BioXcel Forms a Corporate Advisory Board for Its Next Phase of Growth
Date:10/8/2008

NEW HAVEN, Conn., Oct. 8 /PRNewswire/ -- BioXcel Corporation today announced the appointment of three distinguished biopharma executives to its Corporate Advisory Board (CAB). R. Christopher Seaton, SVP of Global Transactions, Bayer Healthcare, Martha Matteo, Ph.D., Past President of SCIP and recently retired from Boehringer Ingelheim Pharmaceuticals, Inc., where she was the Director for Knowledge Management, and Kevin Rakin, Chairman and CEO of Advanced BioHealing, Inc., are known throughout the biopharma world as outstanding and highly experienced pharmaceutical professionals.

BioXcel, a global, business/IP analytics company, will work closely with these industry leaders to design and develop new strategies for its next phase of corporate growth -- targeted to the pharmaceutical, biotechnology, medical device, diagnostic, investment, legal, and related support industries.

"We are delighted to be associated with such a high caliber of experienced pharmaceutical executives," said Vimal D. Mehta, Chairman and co-founder of BioXcel. "Their presence on BioXcel's CAB will assure our planned corporate growth and development at every point in our business model -- from assisting clients with R&D services to all the commercial challenges facing today's complex global industries. BioXcel's senior management, executives, and staff join me in welcoming Christopher, Martha, and Kevin to our valued advisor group. With their advice and guidance, BioXcel is now positioned to achieve our next level of planned business growth, maturity, and service capabilities."

About BioXcel Corporation (http://www.bioxcel.com)

Headquartered in New Haven, CT, BioXcel offers business analytics and intellectual property services to the healthcare sector, life science companies, and related industries worldwide. BioXcel's unique, hybrid delivery model capitalizes on US-based expertise and the BioXcel Analytical and Commercial Center (BACC) in India. This "on-shore/off-shore model" leverages highly flexible analytics teams (MS, MTech, PhDs, MDs, Patent Agents, and MBAs) to provide quality services with outstanding breadth and depth.

For additional information, contact:

Krishnan Nandabalan, Ph.D.

1.203.458.1435

knandabalan@bioxcel.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioXcel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioXcel Expands Its Capability in Business Analytics Support Services
2. NASA technology forms the basis for a new nanotechnology company
3. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
4. iGuard Transforms Drug Safety Alert and Update Process
5. ADM Forms Industrial Chemicals Group
6. Transgenomic, Inc. Forms Scientific Advisory Board
7. Anthera Pharmaceuticals Forms Scientific Advisory Board
8. Technology Transforms Market Research in Pharmaceutical Industry
9. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
10. febit Forms Scientific Advisory Board
11. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/4/2016)... and CAMBRIDGE, Mass. ... , Dec. 4, 2016 SystemOne, a ... diagnostics software platforms for the developing world, and ... Care.™" a reality with its portable and ultrasensitive ... into a development and license agreement to integrate ...
(Date:12/2/2016)... 2, 2016 Amgen (NASDAQ: AMGN ) ... the submission of a Marketing Authorization Application (MAA) to the ... to Avastin ® (bevacizumab). The companies believe this submission ... "The submission of ABP 215 to the ... our oncology portfolio," said Sean E. Harper , M.D., ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic subtyping ... Using molecular test results from tumors with previously documented positive, negative, and ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
Breaking Biology News(10 mins):